Abstract
Human papillomaviruses (HPVs) are important pathogens, as they are the cause of all cervical cancers and of subsets of vulval, anal, oral, and penile cancers. The viral genome is an 8 kb double-stranded circular DNA, which can replicate in various types of epithelial cells. HPV DNA shows changes of its methylation profile during the viral life cycle, namely “sporadic” and “polymorphic” DNA methylation associated with low transcription in basal cells of epithelia, and a lack of methylation in suprabasal cells associated with strong transcription. While these epigenetic changes of HPV DNA during the viral life cycle are still poorly understood, it has emerged that during progression of low-grade precursor lesions to malignant carcinomas, the HPV DNA becomes hypermethylated, probably since the viral genome recombines with the chromosomal DNA of the infected host cell. This methylation signal is intensely studied as a candidate biomarker for the diagnosis of HPV-associated lesions that have the potential to progress to cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44:1755–1762
Badal V, Chuang LSH, Badal S, Tang E, Villa LL, Wheeler CM, Li BFL, Bernard HU (2003) CpG methylation of human papillomavirus-16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77:6227–6234
Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LSH, Li BFL, Bernard HU (2004) The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324:483–492
Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA, Guido-Jimenez MC, Kalantari M, Calleja-Macias IE, Bernard HU, Garcia-Carranca A (2007) Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 120:2165–2169
Bergvall M, Melendy T, Archambault J (2013) The E1 proteins. Virology 445:35–56
Bernard HU (2013) Regulatory elements in the papillomavirus genome. Virology 445:197–204
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM (2010) Classification of papillomaviruses based on 189 PV types and proposal of taxonomic amendments. Virology 401:70–79
Bhattacharjee B, Sengupta S (2006) CpG methylation of HPV16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in the presence of intact E2. Virology 354:280–285
Bodily JM, Mehta KP, Laimins LA (2011) Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res 71:1187–1195
Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK, Martel M, Harigopal M, Schofield K, Neapolitano M (2009) Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 389:100–107
Brandsma JL, Harigopal M, Kiviat NB, Sun Y, Deng Y, Zelterman D, Lizardi PM, Shabanova VR, Levi A, Yaping T, Hu X, Feng Q (2014) Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection. Cancer Prev Res 7:526–533
Bryant D, Onions T, Raybold R, Jones S, Tristram A, Hibbitts S, Fiander S, Powell N (2014) Increased methylation of human papillomavirus type 16 correlates with viral integration in vulval intraepithelial neoplasia. J Clin Virol 61:393–399
Buck CB, Day PM, Trus BL (2013) The papillomavirus major capsid protein L1. Virology 445:169–174
Burgers WA, Blanchon L, Pradhan S, de Launoit Y, Kouzarides T, Fuks F (2007) Viral oncoproteins target the DNA methyltransferases. Oncogene 26:1650–1655
Chaiwongkot A, Vinokurova S, Pientong C, Ekalaksananan T, Kongyingyoes B, Kleebkaow P, Chumworathayi B, Patarapadungkit N, Reuschenbach M, von Knebel Doeberitz M (2013) Differential methylation of E2 binding sites in episomal and integrated HPV16 genomes in preinvasive and invasive cervical lesions. Int J Cancer 132:2087–2094
Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M, Burk RD (2012) Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol Biomark Prev 21:2125–2137
D’Costa ZJ, Jolly C, Androphy EJ, Mercer A, Matthews CM, Hibma MH (2012) Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PLoS One 7:e48954
Dörfler W, Remus R, Müller K, Hohlweg U, Schubbert R (2001) The fate of foreign DNA in mammalian cells and organisms. Dev Biol 106:89–97
Edwards JR, O’Donnell AH, Rollins RA, Peckham HE, Lee C, Milekic MH, Chanrion B, Fu Y, Su T, Hibshoosh H, Gingrich JA, Haghighi F, Nutter R, Bestor TH (2010) Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res 20:972–980
Frimer M, McAndrew T, Smith B, Harari A, Chen Z, Mirabello L, Wentzensen N, Goldberg GL, Rodriguez AZ, Schiffman M, Burk RD (2015) HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study. Gynecol Oncol 138:94–100
Hernandez JM, Siegel EM, Riggs B, Eschrich S, Elahi A, Qu X, Ajidahun A, Berglund A, Coppola D, Grady WM, Giuliano AR, Shibata D (2012) DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One 7:e50533
Hsu CH, Peng KL, Jhang HC, Lin CH, Wu SY, Chiang CM, Lee SC, Yu WC, Juan LJ (2012) The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene 31:2335–2349
Jitesh PV, Risk JM, Schache AG, Dhanda J, Lane B, Liloglou T, Shaw RJ (2013) The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 108:370–379
Johannsen E, Lambert PF (2013) Epigenetics of human papillomaviruses. Virology 445:205–212
Kalantari M, Blennow E, Hagmar B, Johannson B (2001) Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 10:46–54
Kalantari M, Calleja-Macias IE, Tewari K, Hagmar B, Barrera-Saldana HA, Wiley DJ, Bernard HU (2004) Conserved methylation patterns of human papillomavirus-16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78:12762–12772
Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU (2008a) Effects of cellular differentiation, chromosomal integration and treatment by 5′-deoxy-2′ azacytidine on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374:292–303
Kalantari M, Villa LL, Calleja-Macias IE, Bernard HU (2008b) Human papillomavirus-16 and 18 in penile carcinomas: DNA methylation, chromosomal recombination, and genomic variation. Int J Cancer 123:1832–1840
Kalantari M, Osann K, Calleja-Macias IE, Kim S, Yan B, Jordan S, Chase DM, Tewari KS, Bernard HU (2014) Methylation of human papillomavirus 16, 18, 31 and 45 L2 and L1 genes and the cellular DAPK gene: considerations fur use as biomarkers of the progression of cervical neoplasia. Virology 448:314–322
Kim K, Garner-Hamrick RP, Fisher C, Lee D, Lambert PF (2003) Methylation of patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77:12450–12459
Laurson J, Khan S, Chung R, Cross K, Raj K (2010) Epigenetic repression of E-cadherin by human papillomavirus 17 E7 protein. Carcinogenesis 31:918–926
Louvanto K, Franco EL, Ramanakumar AV, Vasiljevic N, Scibior-Bentkowska D, Koushik A, Cusick J, Coutlee F, Lorincz AT, Biomarkers of Cervical Cancer Risk Study Team (2015) Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J Cancer 136:E638–E645
McBride AA (2013) The papillomavirus E2 proteins. Virology 445:57–79
Mine KL, Shulzehenko N, Yambartsev A, Rochman M, Sanson GFO, Lando M, Varma S, Skinner J, Volfovsky N, Deng T, Brenna SMF, Carvalho CRN, Ribalta JCL, Bustin M, Matzinger P, Silva IDCG, Lyng H, Gerbase-DeLima M, Morgun A (2013) Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun 4:1806–1810
Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasilijevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT (2013) Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 132:1412–1422
Mirabello L, Frimer M, Harari A, McAndrew T, Smith B, Chen Z, Wentzensen N, Wacholder S, Castle PE, Raine-Bennett T, Schiffman M, Burk RD (2015) HPV16 methyl-haplotypes determined by a novel next-generation sequencing methods are associated with cervical precancer. Int J Cancer 136:E146–E153
Murakami I, Fujii T, Dan K, Saito M, Ohno A, Iwata T, Aoki D (2013) Methylation of human papillomavirus 52 and 58 is a candidate biomarker in cervical neoplasia. J Clin Virol 58:149–154
Park IS, Chang X, Loyo M, Wu G, Chuang A, Kim M, Chai YK, Lyford-Pike S, Westra WH, Saunders JR, Sidransky D, Pai S (2011) Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers. Cancer Prev Res 4:207–217
Patel DA, Rozek LS, Colacino JA, Zomeren-Dohm V, Ruffin M, Unger ER, Dolinoy DC, Swan DC, Onyekwuluje J, DeGraffinreid CR, Paskett ED (2012) Patterns of cellular and HPV16 methylation as biomarkers for cervical neoplasia. J Virol Methods 184:84–92
Peitsaro P, Johansson B, Syrjaenen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40:886–891
Roman A, Munger K (2013) The papillomavirus E7 proteins. Virology 445:138–168
Rösl F, Arab A, Klevenz B, zur Hausen H (1993) The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol 74:791–801
Sartor MA, Dolinoy DC, Jones TR, Colacino JA, Prince ME, Carey TE, Rozek LS (2011) Genome-wide methylation and expression differences in HPV(+) and HPV(−) squamous cell carcinoma cell lines are consistent with different mechanisms of carcinogenesis. Epigenetics 6:777–787
Saslow D, Solomon D, Lawson HW et al (2012) American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137:516–542
Schuebeler D (2015) Function and information content of DNA methylation. Nature 517:321–326
Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114
Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27–36
Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A, Brown KD (2015) Quantitative DNA methylation analysis of candidate genes in cervical cancer. PLoS One 10:e0122495
Smith JA, Haberstroh FS, White EA, Livingston DM, DeCaprio JA, Howley PM (2014) SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter. Virology 470:311–321
Snellenberg S, Schütze DM, Claassen-Cramer D, Meijer C, Snijders PJ, Steenbergen RD (2012) Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex XMAP system. Virology 422:357–365
Sugarawa K, Fujinaga K, Yamashita T, Ito Y (1983) Integration and methylation of shope papillomavirus DNA in the transplantable Vx2 and Vx7 rabbit carcinomas. Virology 130:88–99
Sun C, Reimers LL, Burk RD (2011) Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 121:59–63
Tan SH, Leong LEC, Walker PA, Bernard HU (1994) The human papillomavirus type 16 transcription factor E2 binds with low cooperativity to two flanking binding sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol 68:6411–6420
Thain A, Jenkins O, Clarke AR, Gaston K (1996) CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 70:7233–7235
Turan T, Kalantari M, Calleja-Macias IE, Villa LL, Cubie HA, Cuschieri K, Skomedal H, Barrera-Saldana HA, Bernard HU (2006) Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 349:175–183
Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU (2007) High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361:185–193
Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broker TR, Moen PT Jr, Chow LT (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78:11172–11186
Vande Pol S, Klingelhutz AJ (2013) Papillomavirus E6 oncoproteins. Virology 445:115–137
Vasiljevic N, Scibior-Bentkowska D, Brentnall A, Cuzick J, Lorincz A (2014) A comparison of the methylation levels in HPV18, HPV31, and HPV33 genomes reveals similar associations with cervical precancers. J Clin Virol 59:161–166
Verhoef VM, Heideman DA, van Kemenade FJ, Rozendaal L, Bosgraaf RP, Hesselink AT, Bekkers RL, Massuger LF, Steenbergen RD, Snijders PJ, Berkhof J, Meijer CJ (2014) Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer. Gynecol Oncol 135:58–63
Vinokurova S, von Knebel Doeberitz M (2011) Differential methylation of the HPV16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One 6:e24451
Wang JW, Roden RBS (2013) L2, the minor capsid protein of papillomaviruses. Virology 445:175–186
Wentzensen N, Sherman ME, Schiffman M, Wang SS (2009) Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 112:293–299
Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD (2012) Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst 104:1738–1749
Wettstein FO, Stevens JG (1983) Shope papillomavirus DNA is extensively methylated in non-virus-producing neoplasms. Virology 126:493–504
Wiley DJ, Huh J, Chang C, Kalantari M, Rao J, Goetz M, Msongsong E, Poulter M, Bernard HU (2005) Methylation of human papillomavirus DNA in samples of HIV-1 infected men screened for anal cancer. J Acqu Immunodef Syndr 39:143–151
Xi LF, Jiang M, Shen Z, Hulbert A, Zhou XH, Lin YY, Kiviat NB, Koutsky LA (2011) Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One 6:e23897
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Bernard, HU. (2017). DNA Methylation of Human Papillomavirus Genomes During Infection and Cancer Progression. In: Doerfler, W., Casadesús, J. (eds) Epigenetics of Infectious Diseases. Epigenetics and Human Health. Springer, Cham. https://doi.org/10.1007/978-3-319-55021-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-55021-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55019-0
Online ISBN: 978-3-319-55021-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)